DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,944,131 | -31.5% | 158,446 | -33.3% | 0.00% | – |
| Q2 2023 | $2,838,185 | +15.4% | 237,704 | +29.2% | 0.00% | – |
| Q1 2023 | $2,458,996 | +30.9% | 183,919 | +110.8% | 0.00% | – |
| Q4 2022 | $1,877,942 | -12.7% | 87,265 | -18.8% | 0.00% | – |
| Q3 2022 | $2,151,000 | +224.9% | 107,405 | +190.0% | 0.00% | – |
| Q2 2022 | $662,000 | +308.6% | 37,040 | +125.1% | 0.00% | – |
| Q1 2022 | $162,000 | -31.4% | 16,453 | +17.8% | 0.00% | – |
| Q4 2021 | $236,000 | +237.1% | 13,964 | +370.6% | 0.00% | – |
| Q3 2021 | $70,000 | +29.6% | 2,967 | +25.0% | 0.00% | – |
| Q2 2021 | $54,000 | – | 2,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |